M&A

Sage sues Biogen as analyst detects little interest in buyout at original offer price
Fierce Pharma
Tue, 01/21/25 - 07:02 pm
SAGE Therapeutics
legal
Biogen
M&A
zuranolone
By the numbers: J&J, GSK lead J.P. Morgan deal announcements in 2025, the largest turnout in years
Pharma Voice
Thu, 01/16/25 - 11:02 am
JPMHC 2025
M&A
JNJ
Intra-Cellular Therapeutics
GSK
IDRx
Under pressure to deal, Biogen executives deflect urgency at JPM25
BioSpace
Wed, 01/15/25 - 11:33 am
Biogen
JPMHC 2025
M&A
Chris Viehbacher
SAGE Therapeutics
5 questions facing emerging biotech in 2025
BioPharma Dive
Tue, 01/14/25 - 11:22 am
biotech
funding
China
IPOs
cell therapy
gene therapy
M&A
Healthcare dealmakers eye M&A resurgence in second Trump term
US News and World Report
Tue, 01/14/25 - 11:18 am
M&A
JPMHC 2025
Donald Trump
Bayer will focus on debt reduction rather than acquisitions in the coming years
Marketscreener
Tue, 01/14/25 - 11:06 am
Bayer
M&A
J&J to buy psychiatric drug developer Intra-Cellular for $14.6B
BioPharma Dive
Mon, 01/13/25 - 11:19 am
JNJ
Intra-Cellular Therapies
JPMHC 2025
M&A
psychiatric disease
New Acquisition to Strengthen Lantheus’s Position in Alzheimer’s Radiodiagnostic Market
Medical Devices and Diagnostics Industry
Mon, 01/13/25 - 11:08 am
Lantheus
Medtech
M&A
Life Molecular
Alzheimer's disease
Sage Therapeutics Stock Soars as Biogen Makes Unsolicited Takeover Bid
Yahoo/Investopedia
Mon, 01/13/25 - 10:54 am
SAGE Therapeutics
Biogen
M&A
Some pharmaceutical mergers lower drug prices: Study
Beckers Hospital Review
Thu, 01/9/25 - 09:15 pm
M&A
drug pricing
Boston Scientific to buy remaining Bolt Medical stake for up to $664M
Medtech Dive
Thu, 01/9/25 - 11:28 am
Boston Scientific
M&A
Medtech
Bolt Medical
Phillips Medisize Boosts Medical Inhaler Portfolio With Vectura Acquisition
Medical Devices and Diagnostics Industry
Wed, 01/8/25 - 11:11 pm
Medtech
Phillips Medisize
M&A
Vectura Group
Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida
Pharma Live
Wed, 01/8/25 - 11:25 am
Roche
M&A
Poseida Therapeutics
blood cancer
Stryker in advanced talks to acquire Inari Medical
Investing.com
Mon, 01/6/25 - 06:47 pm
Medtech
M&A
Stryker
Inari Medical
venous disease
Regeneron Acquisition of Oxular Wipes Out Oxular Workforce
BioSpace
Sun, 01/5/25 - 09:38 pm
Regeneron
Oxular
M&A
layoffs
Analysts predict M&A, IPO uptick in 2025 but don't expect 'floodgates to suddenly open'
Fierce Biotech
Fri, 01/3/25 - 11:17 am
IPOs
M&A
Regeneron acquires UK biotech, adding Oxular's eye disease delivery tech to portfolio
Fierce Biotech
Fri, 01/3/25 - 10:51 am
Regeneron
M&A
Oxular
retinal disease
6 Critical Developments That Could Define the Medical Device Industry in 2025
Medical Devices and Diagnostics Industry
Thu, 01/2/25 - 11:20 am
devices
Medtech
Europe
Medtronic
Abbott Labs
CGMs
JNJ
robotic surgery
Donald Trump
M&A
Medtech M&A Picked Up in 2024, But Belt-Tightening Continues
Medical Devices and Diagnostics Industry
Thu, 12/19/24 - 09:19 pm
Medtech
M&A
Novo completes $16.5bn takeover of Catalent
Pharmaphorum
Thu, 12/19/24 - 10:03 am
Novo Holdings
Catalent
CDMOs
M&A

Pages